Effects of Sublingual Immunotherapy on Grasspollen Allergy

NCT00150514 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2005-09-08

No results posted yet for this study

Summary

The objective of the study is to document the objective immunological effects of SLIT on the nasal mucosa. Better understanding of these immunological pathways, in which this widely practised clinical therapy is likely to work, can only benefit the overall outcome of this, more patient friendly, therapy and it will demonstrate the effects of SLIT on the allergic reaction, with objective parameters, in the nasal tissues showing it to be a true etiological treatment of allergy.

Conditions

  • Hayfever

Interventions

DRUG

Oralgen

PROCEDURE

Nasal biopsy

PROCEDURE

Nasal washing

PROCEDURE

Peak nasal inspiratory flow

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • K Ingels, MD · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Completion
2006-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00150514 on ClinicalTrials.gov